antipsychotics

New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine

No major malformations were associated with olanzapine exposure during the first trimester of pregnancy.

By |2023-03-02T15:52:24-04:00March 1st, 2023|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: No Increase in Major Malformations in Children with Prenatal Exposure to Olanzapine

Accumulating Data on the Reproductive Safety of Second-Generation Antipsychotics, But Still Not Enough

In a cohort of 351 children exposed to second generation antipsychotic during pregnancy, the risk of major congenital malformations did not differ from a comparison group of non-exposed children.

By |2022-12-08T18:32:09-04:00June 21st, 2022|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Risk of Malformations|Comments Off on Accumulating Data on the Reproductive Safety of Second-Generation Antipsychotics, But Still Not Enough

More Data on Second Generation Antipsychotic Medications and Gestational Diabetes

Second-generation antipsychotic medications associated with high metabolic risk (quetiapine, olanzapine, and clozapine) were associated with increased risk of gestational diabetes; other antipsychotics were not.

By |2022-05-26T07:32:11-04:00May 25th, 2022|Psychiatric Disorders During Pregnancy|Comments Off on More Data on Second Generation Antipsychotic Medications and Gestational Diabetes

New Research from the CWMH: No Increase in Major Malformations in Children Prenatally Exposed to Aripiprazole

Despite the increasing use of the newer atypical or second-generation antipsychotic agents to treat a spectrum of psychiatric disorders, including psychotic disorders, bipolar disorder, major depression, PTSD and other anxiety disorders, we have relatively little [...]

By |2021-03-29T13:17:38-04:00March 30th, 2021|Antipsychotic Medications, Outcomes, Pregnancy & Medications, Research at CWMH, Risk of Malformations|Comments Off on New Research from the CWMH: No Increase in Major Malformations in Children Prenatally Exposed to Aripiprazole

Metformin May Help to Treat Menstrual Irregularities in Women Treated with Antipsychotics

Menstrual irregularity is a common side effect of antipsychotic treatment in women, occurring more commonly in those treated with risperidone and the older antipsychotic medications. New research presented at the APA earlier this month indicated that the addition of metformin at 500 mg bid resolved menstrual irregularities in most women treated with antipsychotic medications. (Metformin is a medication used alone or with other medications, including insulin, to treat type 2 diabetes.) In addition, women receiving metformin lost an average 2.4 kg of weight after 6 months of treatment.

By |2015-08-12T15:29:58-04:00May 23rd, 2012|Antipsychotic Medications, General|Comments Off on Metformin May Help to Treat Menstrual Irregularities in Women Treated with Antipsychotics
Go to Top